Gérald Bertrand

1.6k total citations
74 papers, 937 citations indexed

About

Gérald Bertrand is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Gérald Bertrand has authored 74 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 26 papers in Genetics and 22 papers in Immunology. Recurrent topics in Gérald Bertrand's work include Platelet Disorders and Treatments (35 papers), Blood groups and transfusion (34 papers) and Blood disorders and treatments (23 papers). Gérald Bertrand is often cited by papers focused on Platelet Disorders and Treatments (35 papers), Blood groups and transfusion (34 papers) and Blood disorders and treatments (23 papers). Gérald Bertrand collaborates with scholars based in France, Germany and Netherlands. Gérald Bertrand's co-authors include Cécile Kaplan, Corinne Martageix, Vincent Jallu, C. Kaplan, Nicolas Magné, Gersende Alphonse, Claire Rodriguez‐Lafrasse, Antonin Lévy, Dominique Ardail and Moustapha Dramé and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Urology.

In The Last Decade

Gérald Bertrand

71 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gérald Bertrand France 16 559 309 172 121 115 74 937
Judith S. Greengard United States 18 497 0.9× 218 0.7× 336 2.0× 54 0.4× 87 0.8× 26 976
P. M. Lansdorp Canada 12 563 1.0× 105 0.3× 222 1.3× 93 0.8× 191 1.7× 13 827
Masaaki Takatoku Japan 18 658 1.2× 228 0.7× 528 3.1× 323 2.7× 135 1.2× 47 1.1k
O. C. Leeksma Netherlands 14 508 0.9× 89 0.3× 142 0.8× 123 1.0× 252 2.2× 25 826
SD Rowley United States 16 869 1.6× 128 0.4× 231 1.3× 264 2.2× 226 2.0× 25 1.2k
Friedrich Schuening United States 21 617 1.1× 260 0.8× 195 1.1× 198 1.6× 277 2.4× 61 1.0k
R.S. Hill United States 11 570 1.0× 110 0.4× 174 1.0× 185 1.5× 238 2.1× 20 822
Robin Filshie Australia 16 1.1k 2.0× 74 0.2× 173 1.0× 257 2.1× 153 1.3× 41 1.5k
Inge Pareyn Belgium 19 566 1.0× 77 0.2× 153 0.9× 29 0.2× 480 4.2× 43 950
Stern Ac Netherlands 10 590 1.1× 113 0.4× 90 0.5× 438 3.6× 210 1.8× 11 858

Countries citing papers authored by Gérald Bertrand

Since Specialization
Citations

This map shows the geographic impact of Gérald Bertrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Bertrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Bertrand more than expected).

Fields of papers citing papers by Gérald Bertrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Bertrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Bertrand. The network helps show where Gérald Bertrand may publish in the future.

Co-authorship network of co-authors of Gérald Bertrand

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Bertrand. A scholar is included among the top collaborators of Gérald Bertrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Bertrand. Gérald Bertrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perkins, Géraldine, et al.. (2025). Thrombopénie immunologique induite par chimiothérapie : un coupable peut en cacher un autre. La Revue de Médecine Interne. 46(6). 313–319.
2.
Schmitt, François, et al.. (2020). Oxaliplatin and Methylprednisolone-induced Thrombocytopenia and Monocytopenia, Owing to Anti-GPIIbIIIa and -CD36 Antibodies in a Patient With Colorectal Cancer. Clinical Colorectal Cancer. 19(4). e277–e280. 4 indexed citations
3.
Bertrand, Gérald, et al.. (2019). Management of neonatal thrombocytopenia in a context of maternal antiplatelet alloimmunization: Expert opinion of the French-speaking working group. Archives de Pédiatrie. 26(3). 191–197. 3 indexed citations
4.
Lieberman, Lani, Andreas Greinacher, Michael Murphy, et al.. (2019). Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence‐based practice, an international approach. British Journal of Haematology. 185(3). 549–562. 49 indexed citations
5.
Kjær, Mette, Gérald Bertrand, Tamam Bakchoul, et al.. (2018). Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. Vox Sanguinis. 114(1). 79–94. 35 indexed citations
6.
Bertrand, Gérald, et al.. (2015). Genotyping of Human Platelet Antigens by BeadChip Microarray Technology. Methods in molecular biology. 1310. 149–165. 2 indexed citations
7.
Bertrand, Gérald, et al.. (2014). HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness. Transfusion and Apheresis Science. 52(3). 295–299. 8 indexed citations
8.
Bertrand, Gérald, et al.. (2013). HPA‐5 typing discrepancy reveals an Ile503Leu substitution in platelet GPIa (α2 integrin). Vox Sanguinis. 105(1). 73–76. 5 indexed citations
10.
Hallé, L., et al.. (2010). Human platelet antigen allele frequencies in different Algerian populations. Tissue Antigens. 75(6). 673–678. 19 indexed citations
11.
Bertrand, Gérald & C. Kaplan. (2009). Génotypage en immunologie plaquettaire : quand ? Comment ? Limites. Transfusion Clinique et Biologique. 16(2). 164–169. 5 indexed citations
12.
Bertrand, Gérald, et al.. (2009). The new platelet alloantigen Caba: a single point mutation Gln716His on the α2 integrin. Transfusion. 49(10). 2076–2083. 19 indexed citations
13.
Bertrand, Gérald, et al.. (2007). HPA‐13bw neonatal alloimmune thrombocytopenia and low frequency alloantigens: case report and review of the literature. Transfusion. 47(8). 1510–1513. 13 indexed citations
15.
Bertrand, Gérald, Corinne Martageix, Vincent Jallu, Fabien Vitry, & C. Kaplan. (2006). Predictive value of sequential maternal anti‐HPA‐1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis. 4(3). 628–637. 61 indexed citations
16.
Bertrand, Gérald, et al.. (2005). Quantification of human platelet antigen‐1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion. 45(8). 1319–1323. 34 indexed citations
17.
Bertrand, Gérald, Joliette Coste, Christiane Segarra, et al.. (2004). Use of serial analysis of gene expression (SAGE) technology reveals new granulocytic markers. Journal of Immunological Methods. 292(1-2). 43–58. 10 indexed citations
18.
Chautard, Denis, et al.. (2000). Comparison of the Bard Trak™ Test with Voided Urine Cytology in the Diagnosis and Follow–Up of Bladder Tumors. European Urology. 38(6). 686–690. 11 indexed citations
19.
Lorimier, G., et al.. (1995). [Breast micro-opacities of lead origin mimicking microcalcifications].. PubMed. 76(4). 213–5. 2 indexed citations
20.
Page, Michael J., et al.. (1985). Monoclonal anticarcinoembryonic antigen in immunohistochemical studies of colorectal cancer a comparison with tumor and serum carcinoembryonic antigen content. Anticancer Research. 5(6). 601. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026